LYCA
Lycia Therapeutics, Inc.Verdict
We can't put a fair value on LYCA right now. We haven't analysed this company yet.
Follow LYCA
Track it on your watchlist and see the full analysis. Free.
Create a free accountInsider activity
Since Aug 11, 2026: no open-market purchases and 11 other filings (stock awards, tax withholding and similar). Why purchases matter
Other filings
RIEFLIN WILLIAM JL
director · 2026-10-22
Award
$360K
Fischer Laurent
director · 2026-10-22
Award
$360K
Henderson Jane
director · 2026-10-22
Award
$360K
Lee Chin Hyok
Chief Medical Officer · 2026-08-11
Award
$271K
Staben Steven
Chief Scientific Officer · 2026-08-11
Award
$410K
Touami Sofia
Chief Business Officer · 2026-08-11
Award
$254K
RIEFLIN WILLIAM JL
director · 2026-08-11
Award
$92K
Henderson Jane
director · 2026-08-11
Award
$213K
Fischer Laurent
director · 2026-08-11
Award
$49K
Trombley Aetna Wun
President and CEO · 2026-08-11
Award
$1.6M
Bachrodt Amy
Chief Financial Officer · 2026-08-11
Award
$1.5M
Questions about LYCA
Are insiders buying LYCA?
Since Aug 11, 2026: no open-market purchases and 11 other filings (stock awards, tax withholding and similar).
How can I check LYCA's value myself?
Use the free Sticker Price calculator, already filled with LYCA's numbers. Change the growth, P/E or required return and see what you'd pay. Open the calculator →
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of Oct 23, 2026. How the Payback Price works